BRPI0810670A2 - composições de tolperisona - Google Patents

composições de tolperisona

Info

Publication number
BRPI0810670A2
BRPI0810670A2 BRPI0810670A BRPI0810670A BRPI0810670A2 BR PI0810670 A2 BRPI0810670 A2 BR PI0810670A2 BR PI0810670 A BRPI0810670 A BR PI0810670A BR PI0810670 A BRPI0810670 A BR PI0810670A BR PI0810670 A2 BRPI0810670 A2 BR PI0810670A2
Authority
BR
Brazil
Prior art keywords
tolperisone
compositions
tolperisone compositions
Prior art date
Application number
BRPI0810670A
Other languages
English (en)
Inventor
Kälz Beate
Gaeta Frederico
Rothenburger Jan
Gungl József
Gerdes Klaus
Welzig Stefan
Original Assignee
Avigen Inc
Sanochemia Pharmazeutika Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Avigen Inc, Sanochemia Pharmazeutika Ag filed Critical Avigen Inc
Publication of BRPI0810670A2 publication Critical patent/BRPI0810670A2/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4453Non condensed piperidines, e.g. piperocaine only substituted in position 1, e.g. propipocaine, diperodon
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/10Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms
    • C07D295/104Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/108Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/14Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/145555Hetero-N

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
BRPI0810670A 2007-04-26 2008-04-24 composições de tolperisona BRPI0810670A2 (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
AT6582007 2007-04-26
AT0195307A AT505225A1 (de) 2007-04-26 2007-11-29 0erfahren zur herstellung von hoch reinem 2,4'-dimethyl-3-piperidino-propiophenon (tolperison), dieses enthaltende pharmazeutische zusammensetzungen, sowie tolperison enthaltende wirkstoffformulierungen
US2379908P 2008-01-25 2008-01-25
PCT/US2008/005281 WO2008133937A2 (en) 2007-04-26 2008-04-24 Compositions of tolperisone

Publications (1)

Publication Number Publication Date
BRPI0810670A2 true BRPI0810670A2 (pt) 2017-05-09

Family

ID=39944530

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0810670A BRPI0810670A2 (pt) 2007-04-26 2008-04-24 composições de tolperisona

Country Status (13)

Country Link
US (7) US8372979B2 (pt)
EP (2) EP2146976A2 (pt)
JP (2) JP5377473B2 (pt)
KR (2) KR20100031095A (pt)
CN (2) CN101679329A (pt)
AT (1) AT505225A1 (pt)
BR (1) BRPI0810670A2 (pt)
CA (2) CA2685268C (pt)
ES (1) ES2587369T3 (pt)
HU (1) HUE028942T2 (pt)
MX (2) MX2009011543A (pt)
RU (1) RU2009143670A (pt)
WO (2) WO2008133937A2 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT505225A1 (de) 2007-04-26 2008-11-15 Sanochemia Pharmazeutika Ag 0erfahren zur herstellung von hoch reinem 2,4'-dimethyl-3-piperidino-propiophenon (tolperison), dieses enthaltende pharmazeutische zusammensetzungen, sowie tolperison enthaltende wirkstoffformulierungen
HUP0700828A2 (en) * 2007-12-20 2010-01-28 Richter Gedeon Nyrt Transdermal pharmaceutical compositions containing tolperisone alone and in combination
US20100249423A1 (en) 2009-03-09 2010-09-30 Sanochemia Pharmazeutika Ag Tolperisone controlled release tablet
KR101156054B1 (ko) * 2011-09-05 2012-06-20 주식회사 네비팜 안정한 에페리손 함유 서방성 의약조성물
AU2014251038A1 (en) 2013-04-08 2015-11-26 Dennis M. Brown Therapeutic benefit of suboptimally administered chemical compounds
CN107868065B (zh) * 2017-10-19 2021-05-18 湖北美林药业有限公司 一种盐酸托哌酮化合物及其制备方法
US20200390754A1 (en) * 2017-11-17 2020-12-17 Neurana Pharmaceuticals, Inc. Methods of administering tolperisone
CN110412141A (zh) * 2018-04-28 2019-11-05 人福普克药业(武汉)有限公司 一种测定盐酸金刚烷胺软胶囊残留溶剂异丙醇的方法
TR201820976A2 (tr) * 2018-12-28 2020-07-21 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Fi̇ngoli̇mod ve bi̇r spazmoli̇ti̇k i̇çeren farmasöti̇k kombi̇nasyonlar
CN110845443B (zh) * 2019-12-11 2023-09-05 嘉实(湖南)医药科技有限公司 一种制备高纯度盐酸托哌酮的方法
WO2021146425A1 (en) * 2020-01-14 2021-07-22 Neurana Pharmaceuticals, Inc. Methods of treating acute muscle spasms

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5191315A (ja) * 1975-02-06 1976-08-10 Anteinaensantoruperizonshirotsupunoseizoho
JPS5340779A (en) 1976-09-21 1978-04-13 Nippon Kayaku Co Ltd Optically active tolpertisone, their preparation and pharmaceuticals containting the same
JPS607627B2 (ja) * 1977-08-02 1985-02-26 旭化成株式会社 ピペリジン誘導体の製造方法
JPS5430178A (en) 1977-08-05 1979-03-06 Asahi Chem Ind Co Ltd Preparation of propiophenone derivative
JPS5432480A (en) 1977-08-19 1979-03-09 Asahi Chem Ind Co Ltd Novel preparation of piperidine derivatives
JPS5436274A (en) 1977-08-24 1979-03-16 Asahi Chem Ind Co Ltd Preparation of propiophenone derivative
JPS6143108A (ja) 1984-08-03 1986-03-01 Nippon Shinyaku Co Ltd 医薬品製剤及びその製造法
DK162986A (da) 1985-04-12 1986-10-13 Forest Laboratories Terapeutisk middel i enhedsdosisform
JPH0720866B2 (ja) 1987-05-15 1995-03-08 三生製薬株式会社 エペリゾン又はトルペリゾン或いはそれらの塩類含有経皮適用製剤
IL87710A (en) 1987-09-18 1992-06-21 Ciba Geigy Ag Covered floating retard form for controlled release in gastric juice
DE3803482A1 (de) 1988-02-05 1989-08-17 Lohmann Therapie Syst Lts Schwimmfaehiges orales therapeutisches system
JPH045283A (ja) 1990-04-24 1992-01-09 Toyo Pharma- Kk アミノプロピオフェノン誘導体又はその塩の製造方法
EP0717988B1 (en) 1993-08-20 2001-10-17 Nippon Shinyaku Company, Limited Gastric remaining preparation, swollen molding, and production process
IT1282650B1 (it) 1996-02-19 1998-03-31 Jagotec Ag Compressa farmaceutica,caratterizzata da elevato aumento di volume a contatto con liquidi biologici
FR2784583B1 (fr) 1998-10-16 2002-01-25 Synthelabo Composition pharmaceutique a residence gastrique et a liberation controlee
AT409083B (de) 1999-04-01 2002-05-27 Sanochemia Pharmazeutika Ag Pharmazeutische, tolperison enthaltende zubereitung zur oralen verabreichung
US20060013876A1 (en) 2002-06-26 2006-01-19 Lohray Braj B Novel floating dosage form
KR100511492B1 (ko) 2002-10-11 2005-08-31 주식회사 태평양 에페리손, 톨페리손 또는 그것들의 염을 포함하는경피흡수제제
AT413539B (de) 2002-12-05 2006-03-15 Sanochemia Pharmazeutika Ag Verfahren zum herstellen von salzen des tolperison
AT500144A1 (de) 2004-03-05 2005-11-15 Sanochemia Pharmazeutika Ag Tolperison enthaltende, pharmazeutische zubereitung mit steuerbarer wirkstofffreisetzung zur oralen verabreichung
US20060004050A1 (en) 2004-07-02 2006-01-05 Speicher Brian T Compositions and methods for the prevention or treatment of pain and other nervous system disorders
CA2598204C (en) * 2004-11-09 2015-01-13 Board Of Regents, The University Of Texas System Stabilized hme composition with small drug particles
DE102005014080B4 (de) 2005-03-21 2007-11-22 Birds Pharma Gmbh Berolina Innovative Research & Development Services Additionssalze des Tolperison, Verfahren zu deren Herstellung, Verwendung derselben und diese enthaltende Arzneimittel
TW200732292A (en) * 2006-02-01 2007-09-01 Shell Int Research A method of treating an aldehyde mixture, use of the treated aldehyde, and an alcohol
AT505225A1 (de) 2007-04-26 2008-11-15 Sanochemia Pharmazeutika Ag 0erfahren zur herstellung von hoch reinem 2,4'-dimethyl-3-piperidino-propiophenon (tolperison), dieses enthaltende pharmazeutische zusammensetzungen, sowie tolperison enthaltende wirkstoffformulierungen
HUP0700485A3 (en) 2007-07-23 2010-01-28 Richter Gedeon Nyrt Pharmaceutical composition with controlled release containing tolperisone
US20100249423A1 (en) 2009-03-09 2010-09-30 Sanochemia Pharmazeutika Ag Tolperisone controlled release tablet

Also Published As

Publication number Publication date
US20170239228A1 (en) 2017-08-24
EP2146976A2 (en) 2010-01-27
KR20100016123A (ko) 2010-02-12
US20160367540A1 (en) 2016-12-22
US20100324090A1 (en) 2010-12-23
US20180344717A1 (en) 2018-12-06
US20090253743A1 (en) 2009-10-08
CN101679329A (zh) 2010-03-24
MX2009011544A (es) 2010-03-31
WO2008131469A3 (de) 2009-04-23
CN101754958A (zh) 2010-06-23
RU2009143670A (ru) 2011-06-10
KR20100031095A (ko) 2010-03-19
EP2150540A2 (de) 2010-02-10
US9675598B2 (en) 2017-06-13
US8372979B2 (en) 2013-02-12
WO2008133937A2 (en) 2008-11-06
HUE028942T2 (hu) 2017-01-30
AT505225A1 (de) 2008-11-15
WO2008131469A2 (de) 2008-11-06
CA2683634A1 (en) 2008-11-06
JP2010524977A (ja) 2010-07-22
CA2685268A1 (en) 2008-11-06
JP5377473B2 (ja) 2013-12-25
US9315480B2 (en) 2016-04-19
JP2010525060A (ja) 2010-07-22
WO2008133937A3 (en) 2008-12-24
US9662317B2 (en) 2017-05-30
MX2009011543A (es) 2009-12-08
US20100150995A1 (en) 2010-06-17
ES2587369T3 (es) 2016-10-24
CA2685268C (en) 2016-08-02
EP2150540B1 (de) 2016-06-01
US20160220549A1 (en) 2016-08-04

Similar Documents

Publication Publication Date Title
BRPI0810634A2 (pt) Composições fungicidas
BRPI0813775A2 (pt) Composição
BRPI0813500A2 (pt) Compostos antivirais
BRPI0815042A2 (pt) Compostos de pirazol
ATE528048T1 (de) Schweisshemmende/desodorierende zusammensetzung
BRPI0821086A2 (pt) Compostos inseticidas
DK2634231T3 (da) Sammensætninger
BRPI0815067A2 (pt) Compostos de biciclotactama substituída
BRPI0716325A2 (pt) Composição antimicrobianas
BRPI0810898A2 (pt) composições agroquímicas
FR2899479B1 (fr) Composition cicatrisante
BRPI0814973A2 (pt) Composições poliolefínicas plastificadas
BRPI0811264A2 (pt) Compostos
BRPI0810557A2 (pt) composição
BRPI0810670A2 (pt) composições de tolperisona
BRPI0722002A2 (pt) composições de desodorante
BRPI0811274A2 (pt) Composição
BRPI0814424A2 (pt) Compostos heterociclila
BRPI0809996A2 (pt) Compostos
BRPI0718141A2 (pt) Composições de frangrâncias
BRPI0811002A2 (pt) Composição biofertilizante
DK2178973T3 (da) Kvældbare sammensætninger
BRPI0820960A2 (pt) composição
BRPI0815181A2 (pt) Compostos
BRPI0816144A2 (pt) Composição

Legal Events

Date Code Title Description
B08F Application fees: application dismissed [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]